HCM
Hilton Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,052
| Closed | -$1.36M | – | 172 |
|
|
2025
Q1 | $1.36M | Buy |
9,052
+1,014
| +13% | +$153K | 0.12% | 118 |
|
|
2024
Q4 | $1.48M | Buy |
8,038
+380
| +5% | +$70.1K | 0.13% | 110 |
|
|
2024
Q3 | $1.51M | Buy |
7,658
+1,135
| +17% | +$224K | 0.12% | 110 |
|
|
2024
Q2 | $1.35M | Buy |
6,523
+163
| +3% | +$33.7K | 0.11% | 112 |
|
|
2024
Q1 | $1.72M | Buy |
6,360
+3,571
| +128% | +$968K | 0.15% | 98 |
|
|
2023
Q4 | $659K | Buy |
+2,789
| New | +$659K | 0.07% | 101 |
|
|
2021
Q4 | – | Sell |
-500
| Closed | -$206K | – | 128 |
|
|
2021
Q3 | $206K | Sell |
500
-84
| -14% | -$34.6K | 0.02% | 119 |
|
|
2021
Q2 | $216K | Buy |
+584
| New | +$216K | 0.02% | 115 |
|
|
2021
Q1 | – | Sell |
-813
| Closed | -$203K | – | 126 |
|
|
2020
Q4 | $203K | Sell |
813
-315
| -28% | -$78.7K | 0.02% | 96 |
|
|
2020
Q3 | $255K | Sell |
1,128
-260
| -19% | -$58.8K | 0.03% | 67 |
|
|
2020
Q2 | $242K | Buy |
+1,388
| New | +$242K | 0.03% | 70 |
|
|
2020
Q1 | – | Sell |
-1,451
| Closed | -$222K | – | 65 |
|
|
2019
Q4 | $222K | Buy |
1,451
+537
| +59% | +$82.2K | 0.03% | 97 |
|
|
2019
Q3 | $121K | Buy |
914
+168
| +23% | +$22.2K | 0.02% | 141 |
|
|
2019
Q2 | $106K | Sell |
746
-66
| -8% | -$9.38K | 0.01% | 155 |
|
|
2019
Q1 | $118K | Buy |
+812
| New | +$118K | 0.02% | 146 |
|